Abstract

BackgroundCD8+ T cells recognize HIV-1 epitopes translated from a gene’s primary reading frame (F1) and any one of its five alternative reading frames (ARFs) in the forward (F2, F3) or reverse (R1-3) directions. The 3’ end of HIV-1’s proviral coding strand contains a conserved sequence that is directly overlapping but antiparallel to the env gene (ARF R2) and encodes for a putative antisense HIV-1 protein called ASP. ASP expression has been demonstrated in vitro using HIV-transfected cell lines or infected cells. Although antibodies to ASP were previously detected in patient sera, T cell recognition of ASP-derived epitopes has not been evaluated. We therefore investigated the ex vivo and in vitro induction of ASP-specific T cell responses as a measure of immune recognition and protein expression during HIV-1 infection.ResultsA panel of overlapping peptides was initially designed from the full-length ASP sequence to perform a global assessment of T cell responses. Recognition of ASP-derived antigens was evaluated in an IFN-γELISpot assay using PBMCs from HIV-1 seropositive and seronegative individuals. Eight of 25 patients had positive responses to ASP antigens and none of the seronegative donors responded. As a complimentary approach, a second set of antigens was designed using HLA-I binding motifs and affinities. Two ASP-derived peptides with high predicted binding affinities for HLA-A*02 (ASP-YL9) and HLA-B*07 (ASP-TL10) were tested using PBMCs from HIV-1 seropositive and seronegative individuals who expressed the matching HLA-I-restricting allele. We found that HLA-I-restricted ASP peptides were only recognized by CD8+ T cells from patients with the relevant HLA-I and did not induce responses in any of the seronegative donors or patients who do not express the restrictive HLA alleles. Further, ASP-YL9-specific CD8+ T cells had functional profiles that were similar to a previously described HLA-A*02-restricted epitope (Gag-SL9). Specific recognition of ASP-YL9 by CD8+ T cells was also demonstrated by tetramer staining using cells from an HLA-A*02 HIV-infected patient.ConclusionOur results provide the first description of CD8+ T cell-mediated immune responses to ASP in HIV-1-infected patients, demonstrating that ASP is expressed during infection. Our identification of epitopes within ASP has implications for designing HIV vaccines.Electronic supplementary materialThe online version of this article (doi:10.1186/s12977-015-0135-y) contains supplementary material, which is available to authorized users.

Highlights

  • CD8+ T cells recognize Human immunodeficiency virus type I (HIV-1) epitopes translated from a gene’s primary reading frame (F1) and any one of its five alternative reading frames (ARFs) in the forward (F2, F3) or reverse (R1-3) directions

  • antisense protein (ASP)-overlapping peptides induce IFN-γ T cell responses in HIV seropositive patients Immune responses to ASP were first studied using peripheral blood mononuclear cells (PBMCs) from HIV-1 subtype B seropositive patients (Pats.1 to 25, Additional file 1: Table S1) who were off antiretroviral therapy (ART) and 10 seronegative donors (SN)

  • T cell responses were measured with an ex vivo interferon gamma (IFN-γ)-ELISpot assay using a pool of peptides encompassing the whole ASP sequence (85 peptides, 14-18-mers overlapping by 10)

Read more

Summary

Introduction

CD8+ T cells recognize HIV-1 epitopes translated from a gene’s primary reading frame (F1) and any one of its five alternative reading frames (ARFs) in the forward (F2, F3) or reverse (R1-3) directions. ASP expression has been demonstrated in vitro using HIV-transfected cell lines or infected cells. We investigated the ex vivo and in vitro induction of ASP-specific T cell responses as a measure of immune recognition and protein expression during HIV-1 infection. Strategies for developing effective host immunity and protection against HIV-1 infection or lifelong control of the virus are urgently needed. Delayed disease progression has been correlated with the detection of Gag-specific CTLs and the presence of protective human leukocyte antigen class I (HLA-I) alleles, which effectively present HIV-1 derived epitopes for immune recognition [6,7,8,9,10]. Protection against HIV will likely require a vaccine that affords immediate CTL recognition of infected cells through sustained presentation of conserved T cell epitopes

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.